US Patent 11268966 Biomarkers of autism spectrum disorder
Patent 11268966 was granted and assigned to Stemina Biomarker Discovery on March, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11268966 Biomarkers of autism spectrum disorder
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.